111 related articles for article (PubMed ID: 35403794)
1. Node negative duodenal adenocarcinoma is associated with long-term patient survival following pancreaticoduodenal resection.
Patel PH; Likos-Corbett M; Doyle J; Kumar S; Bhogal RH
ANZ J Surg; 2022 May; 92(5):1105-1109. PubMed ID: 35403794
[TBL] [Abstract][Full Text] [Related]
2. Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter?
Sakamoto T; Saiura A; Ono Y; Mise Y; Inoue Y; Ishizawa T; Takahashi Y; Ito H
Ann Surg Oncol; 2017 Oct; 24(11):3368-3375. PubMed ID: 28799027
[TBL] [Abstract][Full Text] [Related]
3. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
4. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
5. Duodenal adenocarcinoma: Surgical results of 27 patients treated at a single center.
López-Domínguez J; Busquets J; Secanella L; Peláez N; Serrano T; Fabregat J
Cir Esp (Engl Ed); 2019 Nov; 97(9):523-530. PubMed ID: 31563268
[TBL] [Abstract][Full Text] [Related]
6. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
[TBL] [Abstract][Full Text] [Related]
8. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
9. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes in patients with duodenal adenocarcinoma.
Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
[TBL] [Abstract][Full Text] [Related]
11. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.
Yeo CJ; Cameron JL; Sohn TA; Coleman J; Sauter PK; Hruban RH; Pitt HA; Lillemoe KD
Ann Surg; 1999 May; 229(5):613-22; discussion 622-4. PubMed ID: 10235519
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis.
Meijer LL; Alberga AJ; de Bakker JK; van der Vliet HJ; Le Large TYS; van Grieken NCT; de Vries R; Daams F; Zonderhuis BM; Kazemier G
Ann Surg Oncol; 2018 Sep; 25(9):2681-2692. PubMed ID: 29946997
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of disease free survival after radical resection for primary duodenal adenocarcinoma].
Jiang QL; Huang XH; Zhang JW; Zhang SS; Wang CF
Zhonghua Yi Xue Za Zhi; 2016 Nov; 96(42):3393-3397. PubMed ID: 27866532
[No Abstract] [Full Text] [Related]
15. Pancreaticoduodenal resection for malignancy in a low-volume center: long-term outcomes from a developing country.
Bhatti AB; Yusuf MA; Kazmi SA; Syed AA
World J Surg; 2014 Oct; 38(10):2506-13. PubMed ID: 24858190
[TBL] [Abstract][Full Text] [Related]
16. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
17. Para-aortic lymph node sampling in pancreatic head adenocarcinoma.
Schwarz L; Lupinacci RM; Svrcek M; Lesurtel M; Bubenheim M; Vuarnesson H; Balladur P; Paye F
Br J Surg; 2014 Apr; 101(5):530-8. PubMed ID: 24633831
[TBL] [Abstract][Full Text] [Related]
18. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
[TBL] [Abstract][Full Text] [Related]
19. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.
Yeo CJ; Cameron JL; Lillemoe KD; Sitzmann JV; Hruban RH; Goodman SN; Dooley WC; Coleman J; Pitt HA
Ann Surg; 1995 Jun; 221(6):721-31; discussion 731-3. PubMed ID: 7794076
[TBL] [Abstract][Full Text] [Related]
20. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients.
Rose DM; Hochwald SN; Klimstra DS; Brennan MF
J Am Coll Surg; 1996 Aug; 183(2):89-96. PubMed ID: 8696551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
